Medi Assist Ser.
Medi Assist Ser. Q1 FY26 earnings call: Revenue & Margins
Q1 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Medi Assist generally aims to grow at or faster than the industry growth rate. - The acquisition of Paramount Health Services is expected to add meaningful growth from Q2 FY'26 due to its sizable scale and portfolio. - Q1 FY'26 saw 19% YoY premium growth, driven by strong new corporate wins (+Rs. No specific forward guidance is provided for FY'26 and FY'27, as stated by management.
From Medi Assist Ser.'s Q1 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Medi Assist generally aims to grow at or faster than the industry growth rate.
- The acquisition of Paramount Health Services is expected to add meaningful growth from Q2 FY'26 due to its sizable scale and portfolio.
- Q1 FY'26 saw 19% YoY premium growth, driven by strong new corporate wins (+Rs. 1,000 crores in Q1 alone).
- Retail premiums growth remains sub-1%, partly due to industry reallocations and a shift toward technology service-based revenues.
- Technology services revenue (including the Star Health partnership) currently contributes 2.5% and is expected to scale up, offering higher gross margins.
- Government business and international benefits (Mayfair) segments are growing well and seen as key growth levers.
2 more points management made on revenue & sales performance
Profitability & Margins
See what Medi Assist Ser. said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The company is aggressive on growth opportunities across multiple dimensions: TPA business, international (IPMI) business, and technology services as a viable line of business.
- Investments are focused on expanding technology capabilities and services.
- Fundraise proceeds are intended for growth-oriented deployment rather than just debt servicing to free up capital for expansion.
- The Board has approved a preferential allotment to bring in long-term, meaningful shareholders to strengthen the capital structure.
- No specific future capex amounts or detailed timelines are disclosed at this time; detailed objectives will be communicated in upcoming shareholder notices.
- The company continues to invest heavily in technology, with current technology spend at 5-7% of revenue.
2 more points management made on capital expenditure plans
Top-ranked in Insurance
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Medi Assist Ser. said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points management made on order book & pipeline
Medi Assist Ser. — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹242 Cr, net profit ₹54 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Medi Assist Ser.'s management said in earlier quarters
Others in Insurance this season
- ICICI Prudential Life Insurance Company Ltd (Q1 FY26)
Q1 growth was impacted by a high base last year (35%+ growth in Q1 FY2025) and softer ULIP demand and regular annuity premiums this year. Key concall takeaways…
- Life Insurance Corporation of India (Q1 FY26)
Individual non-par business is a key focus area, with growth seen in higher-margin products and increased non-par share to 30.34% of individual APE. Key…
- Star Health & Allied Insurance Company Ltd (Q1 FY26)
2,500 crores profit by FY2028 with a broad split of 20% from underwriting and 80% from investment returns. Key concall takeaways from Star Health & Allied…
- General Insuranc (Q1 FY26)
Investment income from interest and dividends runs at approximately INR1,850 crores quarterly, excluding capital gains. Key concall takeaways from General…
Frequently Asked Questions
What were Medi Assist Ser. Q1 FY26 results?
Medi Assist generally aims to grow at or faster than the industry growth rate. - The acquisition of Paramount Health Services is expected to add meaningful growth from Q2 FY'26 due to its sizable scale and portfolio. - Q1 FY'26 saw 19% YoY premium growth, driven by strong new corporate wins (+Rs. No specific forward guidance is provided for FY'26 and FY'27, as stated by management.
What is Medi Assist Ser. share price analysis?
Medi Assist Ser. currently shows a neutral. The stock trades at a P/E of 26.4 with a market cap of ₹2,605 Cr. Investors should review the full earnings analysis for detailed insights.
Is Medi Assist Ser. planning capital expenditure?
The company is aggressive on growth opportunities across multiple dimensions: TPA business, international (IPMI) business, and technology services as a viable line of business.
Keep Medi Assist Ser. on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
